Wolfgang Kastenmüller studies fundamental mechanisms of immune cell development. This knowledge is crucial to develop new targeted therapy approaches. (Image: Gunnar Bartsch/Universität Würzburg)
Wolfgang Kastenmüller studies the development of special immune cells that show promise in treating cancer. He has now been awarded an ERC Consolidator Grant worth nearly two million euros for his research. A little over a year ago, Professor Wolfgang Kastenmüller was appointed Chair of System Immunology I at the University of Würzburg. Together with Georg Gasteiger, who holds the Chair of System Immunology II, he leads the newly established Max Planck Research Group for Systems Immunology. Their research focuses on how the immune system interacts with the organism, especially the interaction of different cells of the immune system in local networks and with cells of other organ systems. Kastenmüller's research efforts have now been rewarded with a EUR 1.8 million Consolidator Grant from the European Research Council ERC. The ERC gives this type of grant to "excellent researchers with a promising scientific career".
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
